(Q33931439)

30 July 2017

1 reference

title

The application of flow cytometry to histocompatibility testing (English)

1 reference

30 July 2017

1 reference

Horsburgh T

1

1 reference

30 July 2017

Martin S

series ordinal

2

1 reference

30 July 2017

Robson AJ

series ordinal

3

1 reference

30 July 2017

publication date

1 March 2000

1 reference

30 July 2017

published in

Transplant Immunology

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

3-15

1 reference

Cruel antibody fictions! Cellular antigen enumeration by 'saturation' binding

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Importance of methodology in the flow cytometric crossmatch: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

T and B cell crossmatching using three-colour flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Measurement of alloantibody by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The significance of a positive flow cytometry crossmatch test in primary kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The flow cytometric crossmatch and early renal transplant loss

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Evaluation of the flow cytometric crossmatch. Preliminary results of a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Detection of alloantibodies by flow cytometry: relevance to clinical transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Significance of the positive crossmatch test in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Impaired renal graft survival after a positive B-cell flow-cytometry crossmatch

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Crossmatching for renal transplantation--a 5-year review of different cytotoxic and flow cytometric methods showing importance of the IgG anti-B-lymphocyte FACS crossmatch

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Clinical implications of flow cytometry B cell crossmatching in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

IgA class antibodies and flow cytometric cross-matching in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The impact of a positive crossmatch upon outcome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The flow cytometric crossmatch in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

A highly sensitive, rapid screening method for the detection of antibodies directed against HLA class I and II antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Acid treatment of lymphocytes selectively decreases the expression of HLA class I antigens: a method to confirm that a positive clinical crossmatch test was due to class I antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Simultaneous HLA Class I and Class II antibodies screening with flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Nomenclature for factors of the HLA system, 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Routine HLA-B27 typing by flow cytometry: differentiation of the products of HLA-B*2702, B*2705 and B*2708

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT)

1 reference

https://api.crossref.org/works/10.1016%2FS0966-3274%2800%2900006-X

7 January 2021

10.1016/S0966-3274(00)00006-X

Identifiers

DOI

1 reference

30 July 2017

1 reference